Neurosurgical Management of Cerebral Palsy

Dec 15, 2023

2 min read

Updated: Nov 3

Archived conference abstract — the research and affiliations below reflect the original event submission. Claims are attributed to the authors; this is not a peer-reviewed journal article or current clinical guidance.

Speaker 1 (HABCHI Nawel): "Image of HABCHI Nawel, presenting on neurosurgical interventions for Cerebral Palsy at the Cerebral Palsy 2023 conference

Speaker 2 (SELLAMI Abdallah): "Image of SELLAMI Abdallah, discussing neurosurgery's role in managing Cerebral Palsy at the Cerebral Palsy 2023 conference.

Title: Neurosurgical Management of Cerebral Palsy

Authors:

Speaker 1: HABCHI Nawel

National hospital for Neurology and Neurosurgery (NHNN) and University of Victoria London United Kingdom

Speaker 2: SELLAMI Abdallah

Neurosurgery Department, Mustapha Pacha University Hospital, Algiers, Algeria

Email: nawelmedbio@yahoo.fr

Volume: Cerebral Palsy 2023_CN50_AA01

International Live Conference on Cerebral Palsy Theme: Enhancing Lives: Understanding and Overcoming Challenges of Cerebral Palsy Date: December 16, 2023 Time: 8:00 PM Indian Standard Time (IST)

Location: Online Registration: Click here

Authors: Speaker 1: HABCHI Nawel National hospital for Neurology and Neurosurgery (NHNN) and University of Victoria London, United Kingdom

Speaker 2: SELLAMI Abdallah Neurosurgery Department, Mustapha Pacha University Hospital, Algiers, Algeria

Abstract

Cerebral palsy (CP) is a neurological disorder affecting movement, muscle tone, and coordination. It is caused by brain damage before or during birth. While neurosurgery is not the primary treatment, certain surgical interventions may be considered in specific cases to manage symptoms or address associated issues. The decision to pursue neurosurgery in CP is made on a case-by-case basis, and not all individuals will require or benefit from surgery.

Some neurosurgical interventions include Selective Dorsal Rhizotomy (SDR), orthopedic

surgeries, Deep Brain Stimulation (DBS), and intrathecal Baclofen Pump. SDR involves

cutting sensory nerve fibers from muscles to enter the spinal cord, while DBS involves

implanting electrodes in specific brain areas to modulate abnormal neural activity and

improve motor function. Baclofen is a muscle relaxant that can be delivered directly into the

spinal fluid, helping reduce spasticity in CP patients.

To determine the most appropriate treatment plan for CP, individuals and their families should work closely with a multidisciplinary team of healthcare professionals, including neurologists, orthopedic surgeons, and physical therapists. The decision to undergo

neurosurgery should be based on a thorough evaluation of the individual's condition, overall health, and treatment goals.

Keywords: Cerebral palsy, neurological disorder, DBS, SDR, Baclofen